about
Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron diseaseVGF Protein and Its C-Terminal Derived Peptides in Amyotrophic Lateral Sclerosis: Human and Animal Model StudiesA genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis.Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.A pilot study evaluating the contribution of SLC19A1 (RFC-1) 80G>a polymorphism to Alzheimer's disease in Italian Caucasians.Leap motion evaluation for assessment of upper limb motor skills in Parkinson's disease.Time course of oxidant markers and antioxidant defenses in subgroups of amyotrophic lateral sclerosis patients.Diffusion tensor MRI and MR spectroscopy in long lasting upper motor neuron involvement in amyotrophic lateral sclerosis.Effect of the 50 bp deletion polymorphism in the SOD1 promoter on SOD1 mRNA levels in Italian ALS patients.Preliminary evaluation of SensHand V1 in assessing motor skills performance in Parkinson disease.Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases.Platelet phenolsulphotransferase activity, monoamine oxidase activity and peripheral-type benzodiazepine binding in demented patients.A permanent emergency: a longitudinal study on families coping with amyotrophic lateral sclerosis.Analysis of extracellular vesicles produced in the biofilm by the dimorphic yeast Pichia fermentans.Quality of life of patients with amyotrophic lateral sclerosis.Platelet monoamine oxidase molecular activity in demented patients.Monoamine oxidase molecular activity in platelets of parkinsonian and demented patients.Decreases in T-cell tumor necrosis factor alpha binding with interferon beta treatment in patients with multiple sclerosis.Age, gender, kinship and caregiver burden in amyotrophic lateral sclerosis.T-lymphocyte interleukin 6 receptor binding in patients with dementia of Alzheimer type.T-lymphocyte immuno-interferon binding in parkinsonian patients.T-lymphocyte tumor necrosis factor-alpha receptor binding in patients with Parkinson's disease.T-cell interferon gamma binding in patients with dementia of the Alzheimer type.Dysphagia in Amyotrophic Lateral Sclerosis: Relationships between disease progression and Fiberoptic Endoscopic Evaluation of Swallowing.TLQP Peptides in Amyotrophic Lateral Sclerosis: Possible Blood Biomarkers with a Neuroprotective Role.Growth hormone secretion is impaired in amyotrophic lateral sclerosis.Spontaneous blinking behaviour in persistent vegetative and minimally conscious states: relationships with evolution and outcome.TNF and sTNFR1/2 plasma levels in ALS patients.Platelet Monoaminooxidase Activity and Behavioural Characteristics in HumansObjective and automatic classification of Parkinson disease with Leap Motion controllerWhole body vibration and treadmill training in Parkinson's disease rehabilitation: effects on energy cost and recovery phases[Neuroimmunomodulation. The bi- and unilateral correlations between the nervous system and the immune system][Susceptibility to multiple sclerosis and T-lymphocyte receptor genes. A synthetic review]Lymphocyte subsets in multiple sclerosis. A study with two-colour fluorescence analysisT-lymphocyte immunointerferon receptors in patients with multiple sclerosis[Immunohistochemical study of the enteric glia in chronic intestinal inflammatory disease]T lymphocyte benzodiazepine binding is reduced in demented patientsImpaired ascendant central pathways conduction in impotent diabetic subjectsT-cell tumor necrosis factor-alpha receptor binding in patients with multiple sclerosisT-cell interleukin-6 receptor binding in interferon-beta-1b-treated multiple sclerosis patients
P50
Q24246738-4C1A9B07-1C38-4B53-AB9D-FEC08ED200F8Q28554689-C8494F3E-9217-4D2D-BA83-44D3F3FAED57Q29417136-365D935F-B4BF-41E6-84EF-6D2680CC7101Q30239103-208EFBCD-4178-4ACB-882D-D7C596AAAE75Q33796669-64B227CD-AB26-49E3-A048-19FFF296BA0FQ38621996-60827EC5-1FCA-466E-8C07-865F9FBE5721Q43163514-97692C00-7772-4624-86E0-2C9443C56E75Q43218925-94008114-30D2-4AED-BE41-C6A5F6C218B1Q43586020-C0B6F981-DEAD-4965-B1BB-C4D6A9A1CDADQ44810914-7B6B6D91-A594-4775-961C-50F64C7CA0C1Q46628274-5147CC4E-B3EF-499D-9796-75E39D665E33Q48001928-E0C424E2-574F-486F-8446-6DE1D9B0FBBFQ48079241-DA691ED9-09E3-4F52-93B5-ABEE78E47D9CQ48167966-26008EF9-01EC-4AF6-BAD8-5C3D9AFC7500Q48486527-0F115A27-C417-41DD-81CB-9ADD46196076Q48687664-BC1D8DD6-815D-4E11-B8AC-8CE159867B7AQ48833631-C4441B19-97E2-4497-8476-C06C630966DFQ50537434-ADE11638-357A-4056-ADC2-58E5459AE8E9Q50683444-C0773C05-BD0F-49FD-B464-62C6E53224BEQ50861797-8769D0B5-9F6E-4446-AFF7-4BE178C384C0Q50949284-3A5A999B-823F-4069-A575-72C9A44BB937Q50953747-30A40520-EDAF-41F4-9B42-F3400FD4008FQ50961198-6441D4F5-A170-4355-A146-F60329BE72A2Q51464496-5CA7DC32-9C56-4978-9183-2D8A5378B115Q51733725-7E8A12FA-AB60-4F74-9CAC-56F5EEC80A5CQ51790175-93AEB854-C392-4F7F-9219-810A85EB17F1Q51986695-6B0513C1-FEAB-485E-932E-B661734FC098Q54067589-7616D90F-C8EB-4BB2-BB82-680B9DCF77ACQ57730656-C7CE4D5E-3ABF-4FB9-846E-F3FFB2D81484Q59340809-A4031B05-2E6C-46DC-A6D5-FC7283AAE763Q64859978-D3B4645F-12A3-4A36-9B1E-D5B1FF3EF215Q70515035-1B858A07-7962-43F7-A1B0-97D13B59E677Q71202134-F589578F-72CC-4EFF-873C-0F0F5008BB86Q71605770-EBC123EC-A1FC-45E8-9A2D-768C367ADE49Q71670834-3F9E2E63-992D-402E-A619-FA79865C0848Q71923042-393A9851-9652-45B2-894F-AF47658308BFQ73128574-72357F20-0AE5-4836-91F9-21945195E0C0Q73217464-F7B78432-580B-45B5-ADE6-6A0C0E0E4807Q73245544-89DA9F55-6EE9-49DE-A490-76BDC0825869Q73341269-B43A05F0-C69C-476A-89EA-925E56A9A608
P50
description
researcher ORCID ID = 0000-0002-0767-1558
@en
wetenschapper
@nl
name
Paolo Bongioanni
@ast
Paolo Bongioanni
@en
Paolo Bongioanni
@es
Paolo Bongioanni
@nl
type
label
Paolo Bongioanni
@ast
Paolo Bongioanni
@en
Paolo Bongioanni
@es
Paolo Bongioanni
@nl
altLabel
P Bongioanni
@en
paolo bongioanni
@en
prefLabel
Paolo Bongioanni
@ast
Paolo Bongioanni
@en
Paolo Bongioanni
@es
Paolo Bongioanni
@nl
P1053
K-4758-2016
P106
P1153
7003393938
P31
P4012
P496
0000-0002-0767-1558